FIELD: chemistry.
SUBSTANCE: invention concerns a method of obtaining of amorphous calcium atorvastatin exhibiting hypolipidemic activity. The method involves dissolution of calcium atorvastin with subsequent precipitation by addition of the resulting solution to a mixture with a solvent precipitator, and filtration of the precipitated amorphous atorvastin.
EFFECT: obtaining amorphous calcium atorvastatin with high purity degree and high output.
5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMORPHOUS CALCIUM ATORVASTATINE PREPARATION METHOD | 2000 |
|
RU2255932C2 |
| PREPARATION OF NONCRYSTALLINE CALCIUM ATORVASTATIN | 2002 |
|
RU2324679C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING ATORVASTATIN PREPARED WITHOUT GRANULATION | 2004 |
|
RU2314804C2 |
| STABLE ATORVASTATIN COMPOSITIONS OBTAINED BY HUMID GRANULATION | 2004 |
|
RU2332211C2 |
| CRYSTALLINE FORMS OF [R[(R*,R*)]-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROL-1-HEPTANOIC ACID | 2004 |
|
RU2315755C2 |
| CRYSTALLINE FORMS VI AND VII OF ATORVASTATIN CALCIUM SALT | 2002 |
|
RU2304139C2 |
| METHOD OF PREPARING AMORPHOUS ATORVASTATINE | 2000 |
|
RU2247113C2 |
| FORM VI OF ATORVASTATIN CALCIUM AND ITS HYDRATES | 2002 |
|
RU2294924C2 |
| METHOD FOR OBTAINING CANNABINOIDS FROM TECHNICAL HEMP VARIETIES | 2018 |
|
RU2796921C2 |
| CRYSTALLINE FUMARATE SALT OF (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)PHENYL][3-HYDROXY-3-(PIPERIDINE-2-YL)AZETIDINE-1-YL]METHANONE | 2016 |
|
RU2762181C2 |
